Additionally, it is challenging to quantify the extent to which the observed damage in studies is attributable to grey matter versus white matter damage.The amounts of GFAP and UCHL-1 detectable in serum provide insights into different aspects of the development and progression of MS. This evidence concerns the gene GFAP and myeloid sarcoma.